Concourse Financial Group Securities, Inc. Cytom X Therapeutics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$1.12 - $1.51 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$1.21 - $5.13 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$1.41 - $2.74 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$1.07 - $1.55 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$1.26 - $1.87 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$1.26 - $1.87 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$1.41 - $1.92 $0 - $0
Q1 2023 May 15, 2023	BUY	$1.48 - $2.88 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$1.19 - $1.91 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$1.23 - $1.97 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$1.53 - $2.89 $0 - $0
Q1 2022 May 09, 2022	BUY	$2.67 - $4.68 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$3.87 - $7.39 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$4.32 - $6.43 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$6.33 - $9.91 $0 - $0
Q1 2021 May 13, 2021	BUY	$6.6 - $9.0 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$6.47 - $7.9 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$6.55 - $8.83 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$7.4 - $14.64 $0 - $0
Q1 2020 May 13, 2020	BUY	$3.61 - $8.6 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$5.17 - $8.91 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$7.38 - $12.25 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$9.35 - $11.41 $0 - $0
Q1 2019 May 15, 2019	BUY	$9.5 - $19.16 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$12.69 - $18.61 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$18.04 - $26.41 $0 - $0

Others Institutions Holding CTMX

# of Institutions

Shares Held

50.4M

Call Options Held

22.3K

Put Options Held

22.9K

Tang Capital Management LLC San Diego, CA

7.79M
Shares

$7.79 Million
1.16% of portfolio
Janus Henderson Group PLC London, X0

6.3M
Shares

$6.3 Million
0.0% of portfolio
Bvf Inc San Francisco, CA

5.23M
Shares

$5.23 Million
0.2% of portfolio
Vanguard Group Inc Valley Forge, PA

4.89M
Shares

$4.89 Million
0.0% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

3M
Shares

$3 Million
0.01% of portfolio

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $66M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account